Fig. 1From: Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center studyFlowchart of the study. *Multiple sites could be positive for ESBL-PE per patients. C3G 3rd generation cephalosporin, ESBL extended-spectrum beta-lactamase, ESBL-PE ESBL producing Enterobacterales, ICU intensive care unitBack to article page